---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-068670"
form_type: "8-K"
ticker: "LIMN"
cik: "0001971387"
company_name: "Liminatus Pharma, Inc."
filed_at: "2025-07-17T23:59:59+00:00"
generated_at: "2026-05-18T06:02:06.366820+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Liminatus Pharma exchanges 1M warrants for 350K shares with Alta Partners

## Summary
- Company issued 350,000 shares of common stock to Alta Partners in exchange for surrender and cancellation of 1,000,000 warrants.
- No commission or other remuneration was paid in connection with the exchange.
- Shares were issued in reliance on the Section 3(a)(9) exemption from registration.
- The transaction reduces potential dilution from outstanding warrants by 650,000 shares on a net basis.

## SEC filing metadata
- accession: 0001104659-25-068670
- form_type: 8-K
- ticker: LIMN
- cik: 0001971387
- company_name: Liminatus Pharma, Inc.
- filed_at: 2025-07-17T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971387/000110465925068670/0001104659-25-068670-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971387/000110465925068670/tm2521089d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-068670
- JSON: https://secwatch.observer/filing/0001104659-25-068670.json
- Plain text: https://secwatch.observer/filing/0001104659-25-068670.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.